Status:
COMPLETED
Prospective Study Using Hybrid PET/MRI to Evaluate Men With Suspected Recurrence Following Treatment for Prostate Cancer
Lead Sponsor:
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
Conditions:
Prostate Cancer
Eligibility:
MALE
19-100 years
Phase:
NA
Brief Summary
Evaluate the impact of hybrid 18F-Fluoro-choline (18F-FCH) PET/MRI imaging on the clinical management of men with suspected recurrent prostate cancer post prostatectomy or radiotherapy. We hypothesiz...
Detailed Description
The study will be a non-randomized, prospective study of men with suspected local recurrence of prostate cancer post-prostatectomy or radiation with negative bone and CT scans. Hybrid PET/MRI using 18...
Eligibility Criteria
Inclusion
- Prostate cancer with rising prostate specific antigen (PSA) post prostatectomy or radiotherapy
- Suspected recurrence based on PSA rise measured on 3 occasions at least 3 months apart and an absolute PSA \> 0.2 ng/mL
- Bone scan and CT scan of the abdomen and pelvis negative for metastatic disease
Exclusion
- Evidence of metastatic disease
- Contradiction to 18F-FCH PET scan
- Contraindication to MRI
Key Trial Info
Start Date :
July 9 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 12 2016
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT01804231
Start Date
July 9 2013
End Date
October 12 2016
Last Update
July 30 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
London Health Sciences Centre
London, Ontario, Canada, N6A 5W9